News
CSII
20.00
0.00%
0.00
*News On Cardiovascular Systems Inc. (CSII) Now Under ABT
Dow Jones · 04/28/2023 21:08
Cytek Biosciences jumps 11% on SmallCap 600 inclusion
Seeking Alpha · 04/25/2023 22:17
Cytek Biosciences Set To Join S&P SmallCap 600, Replacing Cardiovascular Systems
Benzinga · 04/25/2023 21:18
Recent Filing Shows That Sen. Tina Smith Sold Over $100K Worth of Cardiovascular Systems Stock
Benzinga · 04/20/2023 15:05
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA
PR Newswire · 04/11/2023 17:42
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, MAXR
PR Newswire · 04/06/2023 15:35
Cardiovascular completes enrollment in coronary treatment trial
Seeking Alpha · 04/03/2023 20:40
BRIEF-Cardiovascular Systems Completes Enrollment Of Eclipse Clinical Trial
Reuters · 04/03/2023 20:07
More
Webull provides a variety of real-time CSII stock news. You can receive the latest news about Cardiovascular through multiple platforms. This information may help you make smarter investment decisions.
About CSII
Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company has developed orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its peripheral artery disease (PAD) products are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.